Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Frontiers in Oncology|March 26, 2013
PML Degradation: Multiple Ways to Eliminate PMLAndrea Rabellino, Pier Paolo ScaglioniCritical Reviews in Biochemistry and Molecular Biology|March 19, 2020
The implication of the SUMOylation pathway in breast cancer pathogenesis and treatmentAndrea Rabellino, Kum Kum KhannaCurrent Issues in Molecular Biology|August 20, 2019
Roles of Ubiquitination and SUMOylation in the Regulation of AngiogenesisAndrea Rabellino, Cristina Andreani, Pier Paolo ScaglioniCancer Research|March 24, 2017
The Role of PIAS SUMO E3-Ligases in CancerAndrea Rabellino, Cristina Andreani, Pier Paolo ScaglioniMolecular Cancer Research : MCR|March 13, 2014
Nullifying the CDKN2AB locus promotes mutant K-ras lung tumorigenesisKatja Schuster, Niranjan Venkateswaran, Andrea Rabellino, et al.Molecular Immunology|October 16, 2010
Ligation of the BT3 molecules, members of the B7 family, enhance the proinflammatory responses of human monocytes and monocyte-derived dendritic cellsRita Simone, Bernadette Barbarat, Andrea Rabellino, et al.Molecular Biology of the Cell|March 18, 2005
Relationships between EGFR signaling-competent and endocytosis-competent membrane microdomainsClaudia Puri, Daniela Tosoni, Riccardo Comai, et al.EMBO Molecular Medicine|February 24, 2012
Translation-dependent mechanisms lead to PML upregulation and mediate oncogenic K-RAS-induced cellular senescencePier Paolo Scaglioni, Andrea Rabellino, Thomas M Yung, et al.Cancer Research|October 1, 2009
Dual phosphoinositide 3-kinase/mammalian target of rapamycin blockade is an effective radiosensitizing strategy for the treatment of non-small cell lung cancer harboring K-RAS mutationsGeorgia Konstantinidou, Erik A Bey, Andrea Rabellino, et al.Cell Reports|May 31, 2016
PIAS1 Promotes Lymphomagenesis through MYC UpregulationAndrea Rabellino, Margherita Melegari, Van S Tompkins, et al.Pageof 2